4D pharma plc: 4D pharma to Participate in 5th Microbiome Movement Drug Development Summit Europe
4D pharma plc: 4D pharma to Participate in 5th Microbiome Movement Drug Development Summit Europe 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) a novel class of drug derived from the microbiome, today announced its participation in the Microbiome Movement Drug Development Summit Europe, including the Plenary Session, Microbiome Leaders Industry Review Panel. Plenary Session: European Microbiome Leaders Panel Discussion on Thursday, January 28, 2021 at 8:00am GMT (3:00am ET) with Chief Scientific Officer, Dr. Alex Stevenson, ...
Source: finanznachrichten.de